Infection Surveillance Solutions Market Insights
The infection surveillance solutions market was estimated to be worth USD 423.4 million in 2022, with a forecasted compound annual growth rate (CAGR) of 12.2% during the period of 2023 to 2030. It is anticipated that the infection surveillance solutions market will be worth USD 1,034.43 million by the end of 2030.
Application
In healthcare settings such as hospitals, clinics, and long-term care centers, infection surveillance solutions are implemented to monitor, record, and analyze data pertaining to infections. These solutions play a crucial role in identifying and tracking outbreaks, ensuring adherence to infection control protocols, and implementing specific measures to prevent the spread of infections.
Region
The market for infection surveillance solutions is segmented into North America, Europe, Asia-Pacific, and the Rest of the World, with North America emerging as the leading region. Within North America, the United States holds the majority market share, making it the largest market for infection surveillance solutions. This can be attributed to the presence of well-established healthcare infrastructure and a high prevalence of hospital-acquired infections, which act as driving factors in this region.
Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=1982
Segment
The market for infection surveillance solutions is classified into various segments, including product type, deployment mode, end user, and region. The product type segment consists of software, services, and hardware. The deployment mode segment includes cloud-based and on-premise solutions. The end-user segment encompasses hospitals, long-term care facilities, and other healthcare settings.
Market Segmentation
By Component:
Software (On-Premise Software And Web Based Software) and Services (Training Consulting Services, Implementation Services, and Others)
By Infection Type:
Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter-Associated Urinary Tract Infection (CAUTI), and Others
By End-use:
Hospitals, Clinics, Long Term Care Facilities, Academic Institutes and Others.
By Region:
North America, Europe, Asia Pacific, Latin America, and the Middle East Africa
Market value
The growth of the market is driven by the increasing prevalence of hospital-acquired infections, the rising demand for infection control and prevention measures, and the technological advancements in healthcare IT.
In conclusion, the infection surveillance solutions market size is a rapidly growing sector of the healthcare industry, with a projected value of $1.8 billion by 2027. The market is being driven by the increasing need for infection control and prevention in healthcare facilities, as well as the rising prevalence of hospital-acquired infections. The market is segmented by application, region, segment, and market value, and is expected to continue its growth trajectory in the coming years.
The study provides answers to the following key questions:
- What type of customers buying the products and services from companies operating in the Infection Surveillance Solutions Market?
- What will be the roadmap for the product manufacturers operating in the Infection Surveillance Solutions Market for the forecast period, 2023-2030?
- What are the recent developments in the competitive landscape to look out for during the estimated period?
- What are the major trends influencing customers’ lives and their buying behaviour?
- How can brands best communicate with the customers they intend to target?
- When, where and how the customers want to use or consume the products or services?
Contact Us:
Market Research Community
